| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
(S)-N-Methylpyrrolidine-2-methanol does not have a defined pharmacological target as it is a chiral reagent and synthetic intermediate. The compound is used as a chiral building block in asymmetric synthesis and drug discovery. As a chiral pyrrolidine derivative, it serves as a precursor for synthesizing enantiomerically pure pharmaceuticals and bioactive compounds. Its derivatives may target various biological targets depending on the specific modifications made.
|
|---|---|
| ln Vitro |
No specific in vitro pharmacological activity data are available for (S)-N-Methylpyrrolidine-2-methanol as it is a chemical reagent. In research settings, the compound is used as a biochemical reagent for life science research. Its activity is assessed in terms of chiral purity, synthetic utility, and reactivity rather than direct biological activity. The compound is used as a sulfonylation reagent for organic synthesis and drug discovery.
|
| ln Vivo |
No specific in vivo pharmacological activity data have been documented for (S)-N-Methylpyrrolidine-2-methanol as it is not a therapeutic agent. The compound is used exclusively as a research reagent and chiral building block. It is not administered to animals for pharmacological evaluation. Its applications are limited to organic synthesis, medicinal chemistry, and drug discovery laboratories.
|
| Enzyme Assay |
For non-cellular assays, (S)-N-Methylpyrrolidine-2-methanol is characterized by standard analytical techniques including NMR, HPLC, and chiral HPLC to confirm identity, chemical purity, and enantiomeric purity. The compound can be evaluated as a chiral building block in various organic reactions. Typical protocols involve dissolving the compound in appropriate solvents and analyzing reaction products by chromatographic methods. Purity is typically ≥97%. The compound has a LogP of 0.45, 1 hydrogen bond donor, and 2 hydrogen bond acceptors.
|
| Cell Assay |
For in vitro cell-based studies, (S)-N-Methylpyrrolidine-2-methanol is not typically used as a direct test compound. The compound is intended for synthetic chemistry and drug discovery applications. If handled in a biological laboratory context, standard safety precautions should be taken. The compound should be stored in a sealed container protected from light and moisture.
|
| Animal Protocol |
For in vivo animal studies, (S)-N-Methylpyrrolidine-2-methanol can be formulated using common injection vehicles such as DMSO:Tween 80:Saline = 10:5:85 for intravenous, intraperitoneal, intramuscular, or subcutaneous administration. Dosing solutions should be freshly prepared and administered according to specific protocols. The compound is stable at ambient temperature for a few days during shipping.
|
| ADME/Pharmacokinetics |
(S)-N-Methylpyrrolidine-2-methanol has a molecular weight of 115.17 and molecular formula C6H13NO. It has a density of 0.968 g/cm3, boiling point of 164.8°C, flash point of 63.3°C, and refractive index of 1.469. The compound has a LogP of 0.45, 1 hydrogen bond donor, 2 hydrogen bond acceptors, and 1 rotatable bond. Storage: powder at -20°C for 3 years or 4°C for 2 years; in solvent at -80°C for 6 months or -20°C for 1 month.
|
| Toxicity/Toxicokinetics |
(S)-N-Methylpyrrolidine-2-methanol is for research use only and not for human consumption. Standard laboratory safety practices should be followed when handling this chemical. The compound is a flammable liquid and should be kept away from sources of ignition. Appropriate personal protective equipment including gloves and safety glasses should be worn. Specific LD50 values and detailed toxicological profiles have not been extensively reported.
|
| Additional Infomation |
(S)-N-Methylpyrrolidine-2-methanol (CAS 34381-71-0) is also known as N-methyl-L-prolinol, (S)-(-)-1-methyl-2-pyrrolidinemethanol, (S)-(-)-N-methyl-2-pyrrolidinemethanol, and (S)-2-hydroxymethyl-1-methylpyrrolidine. It has an EC number of 251-981-9 and PubChem CID of 643492. The compound is used as a chiral building block in asymmetric synthesis and as a sulfonylation reagent for drug discovery. No clinical trials or therapeutic approvals exist.
|
| Molecular Formula |
C6H13NO
|
|---|---|
| Molecular Weight |
115.17
|
| Exact Mass |
115.099
|
| CAS # |
34381-71-0
|
| PubChem CID |
643492
|
| Appearance |
Colorless to light yellow liquid（Density：0.968 g/cm3）
|
| Density |
1.0±0.1 g/cm3
|
| Boiling Point |
164.8±13.0 °C at 760 mmHg
|
| Flash Point |
63.3±0.0 °C
|
| Vapour Pressure |
0.6±0.7 mmHg at 25°C
|
| Index of Refraction |
1.469
|
| LogP |
0.45
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
2
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
8
|
| Complexity |
74.9
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
OC[C@@H]1CCCN1C
|
| InChi Key |
VCOJPHPOVDIRJK-LURJTMIESA-N
|
| InChi Code |
InChI=1S/C6H13NO/c1-7-4-2-3-6(7)5-8/h6,8H,2-5H2,1H3/t6-/m0/s1
|
| Chemical Name |
[(2S)-1-methylpyrrolidin-2-yl]methanol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 8.6828 mL | 43.4141 mL | 86.8282 mL | |
| 5 mM | 1.7366 mL | 8.6828 mL | 17.3656 mL | |
| 10 mM | 0.8683 mL | 4.3414 mL | 8.6828 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
